 | Up a level |
Milojkovic, Dragana, Cross, Nicholas CP, Ali, Sahra, Byrne, Jenny, Campbell, Gavin, Dignan, Fiona L, Drummond, Mark, Huntly, Brian, Marshall, Scott, McMullin, Mary Frances et al (show 12 more authors)
(2021)
Real-world tyrosine kinase inhibitor treatment pathways, monitoring patterns and responses in patients with chronic myeloid leukaemia in the United Kingdom: the UK TARGET CML study.
BRITISH JOURNAL OF HAEMATOLOGY, 192 (1).
pp. 62-74.
Claudiani, Simone, Janssen, Jeroen JWM, Byrne, Jenny, Smith, Graeme, Blijlevens, Nicole, Raghavan, Manoj, Smith, Matthew, Clark, Richard E 
ORCID: 0000-0002-1261-3299, Mclain-Smith, Susan, Carter, Angela M et al (show 2 more authors)
(2022)
A retrospective observational research study to describe the real-world use of bosutinib in patients with chronic myeloid leukemia in the United Kingdom and the Netherlands.
EUROPEAN JOURNAL OF HAEMATOLOGY, 109 (1).
pp. 90-99.